Executive Succession Planning for Swiss Oncology Biotechnology
13 January, 2025

The CEO Series are the podcasts in which we seek to uncover the secrets of successful leadership in Life Sciences, by speaking to the industry’s most progressive, talented Chief Executives.In this episode, we delve into the world of leadership with Lisa Anson, a distinguished leader and the Chief Executive of Redx Pharmaceuticals. With a rich background that includes a 20-year global career at AstraZeneca, Lisa shares her journey of transitioning from a consulting role at KPMG to steering Redx Pharma out of receivership.